Role of Natural Stilbenes in the Prevention of Cancer

被引：157

作者：

Antoni Sirerol, J. ^{[1
]}

Rodriguez, Maria L. ^{[1
]}

Mena, Salvador ^{[1
]}

Asensi, Miguel A. ^{[1
]}

Estrela, Jose M. ^{[1
]}

Ortega, Angel L. ^{[1
]}

机构：

[1] Univ Valencia, Fac Pharm, Dept Physiol, Ave Vicente Andres Estelles S-N, E-46100 Valencia, Spain

来源：

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | 2016年 / 2016卷

关键词：

NF-KAPPA-B; CHEMOPREVENTIVE AGENT RESVERATROL; QUINONE REDUCTASE 2; CELL-CYCLE ARREST; TRANS-RESVERATROL; IN-VITRO; STEM-CELLS; COLON CARCINOGENESIS; PROSTATE-CANCER; DOWN-REGULATION;

D O I：

10.1155/2016/3128951

中图分类号：

Q2 [细胞生物学];

学科分类号：

071013 [干细胞生物学];

摘要：

Natural stilbenes are an important group of nonflavonoid phytochemicals of polyphenolic structure characterized by the presence of a 1,2-diphenylethylene nucleus. Stilbenes have an extraordinary potential for the prevention and treatment of different diseases, including cancer, due to their antioxidant, cell death activation, and anti-inflammatory properties which associate with low toxicity under in vivo conditions. This review aims to discuss various approaches related to their mechanisms of action, pharmacological activities in animal models and humans, and potential chemoprevention in clinical studies. The biological activity of natural stilbenes is still incompletely understood. Furthermore, after administration to animals or humans, these molecules are rapidly metabolized. Thus pharmacokinetics and/or activities of the natural structures and their metabolites may be very different. Novel drug formulations have been postulated in order to improve stability and bioavailability, to minimize side effects, and to facilitate interaction with their domains in target proteins. These pharmacological improvements should lead stilbenes to become effective candidates as anticancer drugs.

引用

页数：15

共 175 条

[1]

Aggarwal BB, 2004, ANTICANCER RES, V24, P2783

[2]

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death [J].